This is the site of your monthly health newsletter
Home    About the author Disclaimer Link to Net Health Book Links
Last modified Nov. 7, 2006 webmaster@askdrray.com   

Health Newsletter

new every month

current issue April 2005
January 2007 May 2005
previous 2006 issues June 2005
previous 2005 issues July 2005
previous 2004 issues August 2005
previous 2003 issues September 2005
previous 2002 issues October 2005
January 2005 November 2005
February 2005 December 2005
March 2005 table of contents of all issues

January 2005 

HEALTH TOPICS:

Health and Fitness
(health information and
your personal health)
Vol.4, No.1, Jan. 7, 2005
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§

PSA Screening For Prostate Cancer Not Obsolete

Vaccine To Eradicate Cervical Cancer

Doctor Recommended Diet Against Obesity

Bone Loss Non Reversible After Provera

Relapse Of MS Reduced By New Drug

§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§

 

PSA Screening For Prostate Cancer Not Obsolete

Like with any test there are false positive results, and the blood test called PSA (short for Prostate Specific Antigen) has received some criticism as a result. Negative comments likening it to "Shooting flies with a bazooka" have been voiced, and yet, statistics on the mortality due to prostate cancer tell a different story.

In recent years the mortality rate in North America is down by 25%, and part of it is due to PSA. Currently there is no more effective testing in place, so the alternative is not attractive. It is like going back to the bad old times, where men where diagnosed only, once the prostate cancer was advanced, had formed metastases, and hopes for a cure were remote. There are promising new tests under development which at one point in time will replace the PSA, but for now it's still the best test available. The only other way to find prostate cancer is by doing a biopsy.

National Review Of Medicine, December 15,2004, page 22

Return top of health newsletter Table of contents of all issues
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§

Vaccine To Eradicate Cervical Cancer

Dr. Diane M. Harper, a lead researcher from Dartmouth Medical School in New Hampshire has called the results of a vaccination trial against the Human Papilloma Virus (HPV) "extremely exciting and encouraging". A simple vaccination against this virus, which is the cause for cancer of the cervix, has the potential to eradicate the vast majority of cervical cancers worldwide.
The injection in the study was tested on 1,113 women between the ages 15 and 25 over an 18-month period. One hundred percent of the patients of the vaccinated group escaped persistent infection.

The protection against initial HPV- infection was at 92 %.
At this point a much larger trial is set to begin, before the vaccination can be licensed for general use. It will very likely soon be a routine vaccination for young women. If it is successful, it will be a powerful tool for prevention and will save thousands of lives that otherwise would be lost to cervical cancer. Even for those patients who dread shots, a needle prick will be a small price to pay.

National Review Of Medicine, December 15, 2004, page 27

Return top of health newsletter Table of contents of all issues
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§

 

Doctor Recommended Diet Against Obesity

After overindulging over the holidays, new years resolutions often have diets and life style choices high on the list.
These concerns are not something new. Doctors have had concerns about heart disease, diabetes, bulging waistlines and elevated cholesterol. For over three decades there have been concerns that elevated insulin levels may be associated with heart disease, and the constellation of symptoms was called "syndrome X" and later the "insulin resistance syndrome".

 

Most recently the evils that are associated with body fat have been called the "metabolic syndrome".The problem has assumed epidemic proportions: by 2001, 30% of US adults were considered obese with a body mass index of over 30, and 50% were overweight with a body mass index over 25. The form of type 2 diabetes (the adult onset of the disease) is predicted to double in the next 20 years. Physicians are reporting that they are seeing increasing numbers of children who are obese and suffer of type 2 diabetes. The major concern with an accumulation of body fat is the area of the abdomen (think of the "apple shape" with fat around the abdomen). This visceral fat tissue is not just innocently sitting there stopping you from closing buttons and zippers. It is very metabolically active and the substances it releases are a threat to your health. These fat cells secret pro-inflammatory substances called "cytokines."

They also form substances that influence blood-clotting, factors that increase insulin resistance, substances like angiotensin, which are signing responsible for high blood pressure as well. Among the host of damaging substances is also the C-reactive protein, which is recognized as a risk factor for heart disease.
There is only one solution: to reduce the risk, excessive weight has to be shed. A sensible diet to achieve that goal has to contain less saturated fat, more fiber, and low glycemic index carbohydrates. Proper dietary habits are only one part. The other as important measure is life style intervention, which includes 2.5 to 3 hours of moderate exercise per week.
Many of the current diets promise weight loss without compromising health. All of them promote weight loss, provided they are strictly adhered to.

The high protein diets (Atkins, Protein Power Plan) are useful for rapid initial weight loss, however due to the overload of protein long term use is highly questionable. Kidney dysfunction as a consequence is a threat to health and no benefit at all!
Moderate carbohydrate diets, moderate fat, as well as moderate protein will remain the answer for long-term life style changes. It is also of significance that the glycemic index of carbohydrates plays a major role. Food intake, which favors carbohydrates with a low glycemic index, is associated with less heart disease. It has also been documented that insulin levels are more stable. Low glycemic carbohydrates include most vegetables, beans, lentils, as well as fruit like apples, pears and oranges. In contrast, high glycemic carbohydrates result in a fast insulin release, which ultimately leads to insulin resistance. Among these items are potatoes, crackers and other flour products, rice, puffed or flaked breakfast cereals, and tropical fruit (papayas, pineapple, melons).

 

For short-term dieters, it is an option to embark on any of the current diets without deleterious effects, no matter whether they are high-carb or low-carb. But at this point only the diets with moderate carbohydrates have shown to have some benefits on heart health.
Ultimately the wiser choice is to consume foods with a low to moderate glycemic index, by increasing the intake of vegetable proteins and oils and by choosing increased servings of vegetables and fruit instead of highly processed items. So, when you next walk through your supermarket, remember that most of the good stuff is in the periphery, namely the area where all the fresh, unprocessed or minimally processed foods are found.

Metabolic Syndrome Rounds, Oct. 2004, Vol. 2, Issues 8, St. Michael's Hospital, University of Toronto/On/Canada

Return top of health newsletter Table of contents of all issues
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§

 

Bone Loss Non Reversible After Provera

Depo-Provera has been used as an injectable form of contraception, but the manufacturer (Pfizer Canada Inc.) has sent out warnings to physicians about some quite serious side effects. New data have shown that after two years of use significant bone density loss can be seen.

What is more alarming is the fact, that this loss does not seem to be fully reversible, even if the medication is stopped. The effect is bad enough for adults, but it becomes even more alarming should adolescents receive the product: at a time when they should build their bone density, they would be experiencing the problem of bone density loss!

The amounts of bone mineral density is not insignificant: a controlled clinical study showed that women, who received the medication for 5 years showed a decrease of bone density in the spine and hip of 5 to 6 %. If the drug was stopped, there was a partial recovery of the loss, but the longer the drug was used, the less favorable was the recovery of bone density.
There has been some awareness in the past, that loss of bone density could be a risk in the use of Depo-Provera, but there was the thought that all would be well after discontinuing the medication. This however is not the case after the new research data, and it should caution women to stay away from this form of birth control, if they are interested in maintaining good bone health.

The Medical Post, December 7,2004, page4

Return top of health newsletter Table of contents of all issues
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§
 

Relapse Of MS Reduced By New Drug
The effects of MS have been devastating to people afflicted by the disease. New research has brought treatments to combat the progression of the illness, yet relapses after remission have remained perplexing and frustrating to physicians and patients alike. Interferon has been a tremendous help, but patients often experienced flu-like symptoms after receiving interferon. Treatment with steroids has been problematical as well.

The results with Natalizumab (Antegren) are showing impressive results: relapses of MS are reduced by two-thirds (compared to placebo) The drug mechanism works by inhibiting the migration of aggressive auto-immune cells into such tissues as the brain, where they would cause inflammation, which in turn would cause MS lesions. Dr. Paul O'Connor is the lead investigator of the trial and chief of the MS clinic at St. Michael's Hospital in Toronto, and he reports that this new medication gives double the effect compared to previous drugs against MS. MRI scans also showed 90% less new lesions compared to patients who took placebo (ineffective "fake" medication). Compared to previous MS drugs the medication is safe and well tolerated. The administration of the drug has to be done intravenously, so the patient would need to make a trip to a clinic or hospital once a month.

On the strength of the excellent results the approval process of the drug is carried out only after one year of the study. A second study involving approximately 1,200 patients is ongoing, and the manufacturers of natazulinab (Elan Corp. and Biogen Idec Inc.) are anticipating regulatory approval in the United States. They are also seeking the approval of the drug with Health Canada.

Addendum: This drug was withdrawn from the market as can be seen from this link.

The Medical Post, November30, 2004, page 49

Return top of health newsletter Table of contents of all issues
§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§§
 

Health Newsletter

Home page

Nethealthbook